Goldman Sachs Group, Inc. (The) set a €97.00 ($115.48) target price on Fresenius Medical Care AG & Co. KGaA (ETR:FME) in a research report report published on Tuesday morning. The firm currently has a buy rating on the stock.

Several other research analysts have also issued reports on the company. Berenberg Bank set a €95.60 ($113.81) price target on Fresenius Medical Care AG & Co. KGaA and gave the stock a buy rating in a report on Tuesday, September 5th. Citigroup Inc. set a €92.00 ($109.52) price target on Fresenius Medical Care AG & Co. KGaA and gave the stock a buy rating in a report on Tuesday, August 8th. J P Morgan Chase & Co set a €95.10 ($113.21) price target on Fresenius Medical Care AG & Co. KGaA and gave the stock a buy rating in a report on Tuesday, August 8th. Deutsche Bank AG set a €84.00 ($100.00) price target on Fresenius Medical Care AG & Co. KGaA and gave the stock a neutral rating in a report on Tuesday, August 8th. Finally, Independent Research GmbH set a €88.00 ($104.76) price target on Fresenius Medical Care AG & Co. KGaA and gave the stock a neutral rating in a report on Tuesday, August 8th. One research analyst has rated the stock with a sell rating, nine have assigned a hold rating and ten have issued a buy rating to the company. Fresenius Medical Care AG & Co. KGaA currently has an average rating of Hold and a consensus price target of €88.39 ($105.22).

Shares of Fresenius Medical Care AG & Co. KGaA (ETR:FME) opened at 80.711 on Tuesday. The company has a market cap of €24.77 billion and a PE ratio of 20.813. The firm has a 50-day moving average price of €79.21 and a 200 day moving average price of €81.55. Fresenius Medical Care AG & Co. KGaA has a 1-year low of €70.82 and a 1-year high of €89.07.

COPYRIGHT VIOLATION WARNING: “Fresenius Medical Care AG & Co. KGaA (FME) Given a €97.00 Price Target by Goldman Sachs Group, Inc. (The) Analysts” was first reported by The Cerbat Gem and is owned by of The Cerbat Gem. If you are reading this piece on another website, it was illegally stolen and reposted in violation of United States & international copyright & trademark legislation. The original version of this piece can be read at https://www.thecerbatgem.com/2017/09/13/fresenius-medical-care-ag-97-00-price-target-by-goldman-sachs-group-inc-the-analysts.html.

Fresenius Medical Care AG & Co. KGaA Company Profile

Fresenius Medical Care AG & Co KGaA, a kidney dialysis company, provides dialysis care and related services, and other health care services. It offers dialysis treatment, and related laboratory and diagnostic services through a network of outpatient dialysis clinics; materials, training, and patient support services comprising clinical monitoring, follow-up assistance, and arranging for delivery of the supplies to the patient's residence; and dialysis services under contract to hospitals in the United States for the hospitalized ESRD patients and for patients suffering from acute kidney failure.

Analyst Recommendations for Fresenius Medical Care AG & Co. KGaA (ETR:FME)

Receive News & Stock Ratings for Fresenius Medical Care AG & Co. KGaA Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Fresenius Medical Care AG & Co. KGaA and related stocks with our FREE daily email newsletter.